Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology

ConclusionIn theNTRK guideline, the committee proposed 15 recommendations for performingNTRK testing properly to select patients who are likely to benefit from tropomyosin receptor kinase inhibitors.

Source: International Journal of Clinical Oncology - January 23, 2020 Category: Cancer & Oncology Source Type: research